Has Nicholas Papajohn, MD received payments from drug or device companies?

Yes. Drug and device makers reported $26,663 in general payments to Nicholas Papajohn, MD across 617 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nicholas Papajohn, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nicholas Papajohn, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nicholas Papajohn, MD

Dermatology · Miramar Beach, FLNPI 1548425812

Payments from drug & device makers

$26,663in general payments, 2019–2025

Across 617 payments — averaging $43.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$17K
AbbVie$3K
Sun Pharmaceutical Industries Inc.$991
Johnson & Johnson$951
Sanofi$900
Amgen$743
plus $4K from 32 others

What the payments were for

Speaking & faculty fees$15,25057%
Travel & lodging$2621%
Food & beverage$10,89941%
Education$2531%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	65	$16,539
AbbVie(2 entities)	143	$2,641
Sun Pharmaceutical Industries Inc.	55	$991
Johnson & Johnson	55	$951
Sanofi	42	$900
Amgen	37	$743
Lilly USA, LLC	19	$547
Regeneron Healthcare Solutions, Inc.	26	$544
Novartis	23	$371
LEO Pharma Inc.	34	$346
E.r. Squibb & Sons, L.L.C.	22	$325
UCB, Inc.	17	$305
Galderma Laboratories, L.p.	16	$247
Incyte Corporation	10	$167
Boehringer Ingelheim	9	$164
Janssen Scientific Affairs, LLC	3	$116
DUSA Pharmaceuticals, Inc.	4	$82
Arcutis Biotherapeutics, Inc.	4	$65
Verrica Pharmaceuticals Inc.	3	$65
Biofrontera Inc.	3	$61
Genentech USA, Inc.	3	$54
Ortho Dermatologics, A Division Of Bausch Health US, LLC	3	$53
Merz North America, Inc.	1	$50
Almirall LLC	2	$49
Bristol Myers Squibb	3	$47
Dermira, Inc.	2	$28
ANI Pharmaceuticals, Inc.	1	$25
Mallinckrodt Hospital Products Inc.	1	$22
Blueprint Medicines Corporation	1	$22
Kyowa Kirin, Inc.	1	$22
VYNE Pharmaceuticals Inc.	1	$19
Aclaris Therapeutics, Inc.	1	$17
Helsinn Therapeutics (U.S.), Inc.	1	$16
Organogenesis Inc.	1	$15
Dermavant Sciences, Inc.	1	$15
Mayne Pharma Commercial LLC	1	$14
EPI Health, LLC	1	$12
Organon	2	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EUCRISA$15,485
EBGLYSS$122
Humira$110

How this compares

$26,663 in reported general payments places this provider in the 80th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida →

Medicare billing

Part B allowed, 2024

$804,032

Medicare patients

1,509

Services billed

13,663

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab	18	$216,599
Dupixent PenDupilumab	33	$125,320
Clobetasol Propionate	104	$5,174
Doxycycline Hyclate	83	$2,483
Ketoconazole	135	$2,159
Triamcinolone Acetonide	136	$1,842
ValacyclovirValacyclovir Hcl	50	$1,331
Fluocinolone AcetonideFluocinolone/Shower Cap	14	$1,293
Minocycline Hcl	34	$1,174
Desonide	23	$1,127
Metronidazole	12	$1,113
Fluocinonide	33	$1,073
Mometasone Furoate	53	$911
Clindamycin Phosphate	24	$787
Hydroxychloroquine Sulfate	11	$672

Paid to pharmacies, not to this prescriber.

Other dermatology in Miramar Beach

Michael SherlingLake Worth$78.9M
Seth FormanTampa$28.2M
Thomas TaylorTampa$13.6M
Frank DonHallandale Beach$7.5M
Francisco FloresMiramar$6.7M
Hector Wiltz JrMiami$6.4M
Javier Alonso-LlamazaresCoral Gables$5.6M
Eduardo WeissHollywood$5.5M
Francisco KerdelMiami$5.1M
Jason SluzevichJacksonville$4.8M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →